HELPS CREATE A HEALTHIER WORLD THROUGH EXCELLENCE

Discover our innovative MMCR oral liquid technology.

CDMO

As a CDMO or “Contract Development and Manufacturing Organisation”, BePharBel Manufacturing provides a comprehensive and integrated solution for the development and the production of your pharmaceutical products. Our CDMO unit offers a genuine end-to-end solution combined with a strong commitment to quality. The result is a rapid and optimised development of your medicines (small molecules – including antibiotics) and medical devices

GALENIC
DEVELOPMENT

PRODUCTION

ANALYTICAL
SERVICES

Our strengths: the development of new formulations and the reformulation of old formulas, or how to reveal the full potential of active ingredients which have already proven successful!

Our commitment: quality and innovation for patients, global solution and flexibility for our partners

MMCR

NEW PATENT

The revolutionary MMCR technology (Multi-layer Micro-particle Controlled Release) enables the development of a controlled release syrup (sustained or delayed).

Are you interested by a MMCR co-development project?

Founded in 2012 on the initiative of a group of experienced and active players in Belgian and international pharmaceutical development, our company is continually strengthening its position in Belgium and Europe after among others, the takeover of assets belonging to Propharex (2012), ERFA Pharm (2014), Econophar (2015) and Lagepha (2017). Today, BePharBel Manufacturing handles more than 10 different galenic forms, both sterile and non-sterile, as well as more than 40 finished products.